Our seasoned investment team brings over 50 years combined biotech venture capital and company building experience from top tier funds including Novo Ventures, TPG Biotech, Bay City Capital, NEA, and SV Life Sciences. We strive to leverage this extended network and expertise in evaluating new investment opportunities, building value in our portfolio, and in contributing management talent and referrals to our companies. We invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. We are capable of leading or co-leading transactions, and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.